PRDM1 rs2185379, unlike BRCA1, is not a prognostic marker in patients with advanced ovarian cancer.

doi:10.3233/CBM-230358

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

PRDM1 rs2185379, unlike BRCA1, is not a prognostic marker in patients with advanced ovarian cancer.

Cancer biomarkers : section A of Disease markers - 1 Jan 2024

Horackova Klara, Vocka Michal, Lopatova Sarka, Zemankova Petra, Kleibl Zdenek, Soukupova Jana

Abstract excerpt

BACKGROUND: Ovarian cancer (OC) is mostly diagnosed in advanced stages with high incidence-to-mortality rate. Nevertheless, some patients achieve long-term disease-free survival. However, the prognostic markers have not been well established. OBJECTIVE: The primary objective of this study was to analyse the association of the suggested prognostic marker rs2185379 in PRDM1 with long-term survival in a large...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aged, 80 and over

Share to Biomarkers, Tumor

Share to BRCA1 Protein

Share to Neoplasm Staging

Share to Ovarian Neoplasms

Share to Positive Regulatory Domain I-Binding Factor 1

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 38607753
DOI: 10.3233/CBM-230358
PMCID: PMC11321493

Genes

PRDM1
BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

PRDM1 rs2185379, unlike BRCA1, is not a prognostic marker in patients with advanced ovarian cancer.PMID 38607753Read ↗

Molecular characteristics of early- and late-onset ovarian cancer: insights from multidimensional evidenceSemantic proximity Read ↗

Early-onset ovarian cancer: a comprehensive analysisSemantic proximity Read ↗

A comprehensive analysis of germline predisposition to early-onset ovarian cancer.Semantic proximity Read ↗

Common variants at 19p13 are associated with susceptibility to ovarian cancer.Semantic proximity Read ↗

Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer.Semantic proximity Read ↗

The impact of genetic variants of the IGF-1 axis on surgical outcomes and prognosis in ovarian cancer.Semantic proximity Read ↗

Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer.Semantic proximity Read ↗

The Impact of IGF1 Genetic Variants on Surgical Outcomes and Prognosis in Ovarian CancerSemantic proximity Read ↗

Icb-1 gene polymorphism rs1467465 is associated with susceptibility to ovarian cancer.Semantic proximity Read ↗

ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.